Celltex News
Aging & Disease Reports Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia
The COVID-19 pandemic has the global medical profession working around the clock looking for vaccines and therapies.
The journal Aging & Disease has recently reported on a study that has proven transplantation of mesenchymal stem cells has improved the outcome of 7 patients diagnosed with COVID-19 Pneumonia in Bejing, China. Celltex is continuing to monitor this effective research.
If you currently have your MSCs banked at Celltex and are wondering what options are available to you, please contact the Client Services team today by completing the form on our Request a Consultation page, by calling (713) 590-1000 or sending an email to info@celltexbank.com. If you are not a client but would like to bank your MSCs, please complete our online client assessment and a Client Services Coordinator will contact you.
More Recent News
The Bryan-College Station Eagle: Celltex’s Jackie Sherrill Featured as a Guest Columnist to Comment on the Upcoming Texas A&M vs. Texas Game
Read MoreThe Difference Between Cord Blood Banking and Adult Stem Cell Banking
Cord blood banking is a relatively well-known concept, especially among new or soon-to-be parents. While it does have potential benefits, there may be some confusion about which cells are stored and how they may be used.
In this article, we explore the key differences between cord blood banking and adult stem cell banking.
Read More